The clinical impact of serous tubal intraepithelial carcinoma on outcomes of patients with high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum

Toptas T., Pestereli E., ŞİMŞEK T., Bozkurt S., ERDOĞAN G., Karaveli S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, no.3, pp.587-592, 2018 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 14 Issue: 3
  • Publication Date: 2018
  • Doi Number: 10.4103/0973-1482.172130
  • Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.587-592
  • Keywords: High-grade serous carcinoma, serous tubal intraepithelial carcinoma, survival, PROPHYLACTIC OOPHORECTOMY SPECIMENS, CANCER, ADENOCARCINOMA, FIMBRIA, TUMORS, WOMEN, P53
  • Akdeniz University Affiliated: Yes

Abstract

Aims: To investigate whether the presence of serous tubal intraepithelial carcinoma (STIC) is associated with clinical outcomes in a nonselected (unknown BRCA status) cohort of patients with a high-grade serous carcinoma (HGSC) of the ovary, fallopian tube, and peritoneum.